Since COVID-19 emerged in Canada in March 2020, what physicians, scientists, public health
officials and citizens have understood about the virus and how to address it has changed drastically. The continually evolving information overload is understandably confusing and overwhelming, and the conflicts between information can be difficult to validate.
The following considerations may help you to more clearly consider these challenges:
Public Perceptions | Evidence-Based Considerations |
|---|---|
– COVID-19 poses a serious
threat to public health. | – Risk varies with age and
comorbidities. Children,
adolescents and young adults
have a very low risk of
hospitalization or death from
COVID-19. |
– There is no available,
effective, approved treatment
for COVID-19. | – There are known safe drug
protocols that are effective in
COVID-19 treatment and
prevention. |
– Because healthy people are
considered to transmit the
virus, restrictions (including
social distancing and
lockdowns) are the best way
to reduce transmission of
COVID-19. | – Numerous studies have found
that healthy people do not
significantly contribute to
transmission of the virus.
– Research has shown that the majority of people who have recovered from COVID-19 have developed immunity and do not transmit the virus. – Targeted early treatment and empowering people to build healthy, meaningful, socially connected lives is essential to personal well being and public health. |
– COVID-19 vaccines are
necessary, safe, and effective
(“the benefits outweigh the
risks”), and the fastest and
only way to get back to, and
perpetually maintain normal
life. | – The methods used to justify
rapid COVID-19 vaccine
development and rollout do
not adequately measure
necessity, safety, and efficacy.
– There have been an unprecedented number of deaths and serious, lifealtering adverse reactions occurring shortly after COVID-19 vaccination. – Contrary to initial scientific assumption, the lipid nanoparticles in the COVID-19 vaccines do not stay at the injection site but travel throughout the body, cross the blood-brain barrier, and have been shown to accumulate in sensitive tissues including bone marrow and ovaries. – Much remains unknown about the extremely serious short and long term adverse effects and dangers of the COVID-19 vaccines. These risks need to be independently investigated immediately and resolved before continuing with mass vaccination. |
– All COVID-19 vaccines are
fully approved. | – COVID-19 vaccines are
authorized for use “under
interim order” and are
therefore investigational. The
current experimental phases
are not due to be completed
until 2023 or 2024. |
– “The Science” is settled;
anything contrary to the
official narrative is not
science. | – “The Science” is not settled;
competing evidence about
COVID-19 is growing from many
highly-credentialed sources and
challenges the official narrative.
Compelling scientific evidence is
being ignored or censored.
– In valuing principles of equity, diversity, and inclusion, we need to encourage multiple ways of knowing, and develop public health protocols that are evidence informed and responsive to the overall health and wellbeing of our individuals and communities. |
Dialogue over these issues is difficult, divisive, and threatens to tear us apart. As we navigate this rapidly evolving situation, we believe some ethical and legal principles should remain constant in a free and democratic society:
As caring and responsible individuals, it is crucial that we remain open to listening to each other, continuing to ask questions, and recognizing that we are all doing the best we can to keep those we love safe. This is especially true regarding concerns about scientific and medical issues which have a huge impact on the health and welfare of our population. Our COVID-19 resources are offered as learning tools. Feel free to use the information, forms and FAQs as resources with which to engage your government, representatives, health care providers, family and friends.
Information for parents of school aged children, click here
Information for students heading off to university, click here
Information for those seeking medical advice from their physician, click here
ENTER YOUR SEARCH TERMS AND HIT ENTER
Ms. Deanna McCleod provides an overview of the gaps in the checks and balances in the creation of guidelines surrounding the management of COVID-19.
Nuvaxovid is the brand name for the Novavax COVID-19 vaccine. It is not an mRNA vaccine like Pfizer and Moderna’s versions.
The College of Physicians and surgeons of Ontario recently released their deliberations on a motion hearing by three Ontario physicians. The three medical doctors have had their licenses suspended for acting outside the recommendations of their regulatory college thus providing individualized care to their patients.
Dr. Patrick Provost is a faculty member of Laval University. He shares his experiences with being suspended from his university for publicly challenging the consensus regarding COVID-19 genetic vaccines, particularly for children.
Dr. Claudia Chaufan’s article is an analysis of the medical messaging relating to COVID-19 and the issues with unchallenged consensus.
The CCCA’s open letter and critique in response to the report recently issued by the Council of Canadian Academies (CCA).